What is a stock summary page? Click here for an overview.
Business Description
Alpha Tau Medical Ltd
NAICS : 325412
SIC : 2834
ISIN : IL0011839383
Description
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.75 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | -0.4 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -3.5 | |||||
| 3-Year EPS without NRI Growth Rate | -22.3 | |||||
| 3-Year FCF Growth Rate | -13.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.47 | |||||
| 9-Day RSI | 35.4 | |||||
| 14-Day RSI | 37.04 | |||||
| 3-1 Month Momentum % | -13.55 | |||||
| 6-1 Month Momentum % | 12.84 | |||||
| 12-1 Month Momentum % | -9.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | |||||
| Quick Ratio | 7.4 | |||||
| Cash Ratio | 6.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | -2.52 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -42.95 | |||||
| ROA % | -32.88 | |||||
| ROIC % | -157.65 | |||||
| 3-Year ROIIC % | -158.69 | |||||
| ROC (Joel Greenblatt) % | -150.66 | |||||
| ROCE % | -35.15 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.93 | |||||
| Price-to-Tangible-Book | 2.92 | |||||
| EV-to-EBIT | -4.32 | |||||
| EV-to-EBITDA | -4.32 | |||||
| EV-to-FCF | -6.17 | |||||
| Price-to-Net-Current-Asset-Value | 4.48 | |||||
| Price-to-Net-Cash | 5.1 | |||||
| Earnings Yield (Greenblatt) % | -23.15 | |||||
| FCF Yield % | -11.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DRTS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alpha Tau Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.45 | ||
| Beta | 1.09 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 44.29 | ||
| 14-Day RSI | 37.04 | ||
| 14-Day ATR ($) | 0.184533 | ||
| 20-Day SMA ($) | 2.72401 | ||
| 12-1 Month Momentum % | -9.76 | ||
| 52-Week Range ($) | 1.75 - 4.3866 | ||
| Shares Outstanding (Mil) | 70.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alpha Tau Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alpha Tau Medical Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alpha Tau Medical Ltd Frequently Asked Questions
What is Alpha Tau Medical Ltd(DRTS)'s stock price today?
The current price of DRTS is $2.60. The 52 week high of DRTS is $4.39 and 52 week low is $1.75.
When is next earnings date of Alpha Tau Medical Ltd(DRTS)?
The next earnings date of Alpha Tau Medical Ltd(DRTS) is 2025-05-20 Est..
Does Alpha Tau Medical Ltd(DRTS) pay dividends? If so, how much?
Alpha Tau Medical Ltd(DRTS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers